Mimran A, Ribstein J
Policlinique, Hôpital Lapeyronie, Montpellier.
Arch Mal Coeur Vaiss. 1987 Jun;80(6):835-8.
Calcium blockers of the dihydropyridine group may affect serum potassium level through an influence on the epinephrine mediated fall in serum K+. The effect of epinephrine infusion (12.5, 25 and 50 ng/kg/min) was assessed during placebo and after a 4-day treatment by nitrendipine in normal man. Nitrendipine treatment was associated with an enhancement in the fall of serum potassium induced by epinephrine. By contrast the response of arterial pressure, heart rate as well as the increase in blood glucose, plasma renin activity and the fall in plasma aldosterone and serum insulin levels induced by epinephrine were not affected by nitrendipine. Nitrendipine may potentiate the Na, K-ATPase stimulatory effect of epinephrine. Serum potassium should be carefully monitored in clinical situations associated with a consistent increase in circulating levels of epinephrine.
二氢吡啶类钙通道阻滞剂可能通过影响肾上腺素介导的血清钾降低来影响血清钾水平。在正常男性中,评估了安慰剂期间以及尼群地平治疗4天后肾上腺素输注(12.5、25和50 ng/kg/分钟)的效果。尼群地平治疗与肾上腺素诱导的血清钾下降增强有关。相比之下,肾上腺素诱导的动脉压、心率反应以及血糖升高、血浆肾素活性增加、血浆醛固酮下降和血清胰岛素水平下降均不受尼群地平影响。尼群地平可能增强肾上腺素对钠钾ATP酶的刺激作用。在与循环中肾上腺素水平持续升高相关的临床情况下,应仔细监测血清钾。